BioSpace News Archive

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, announced today that clinical data from its NeuroStar Outcomes Registry, which suggests NeuroStar Advanced Therapy be evaluated as a first-line treatment for Major Depressive Disorder (MDD), will be published in the December 2020

The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Date October 13, 2020 Time 11:30 AM (EDT) Location Sir John A Macdonald Building, Room 200 144 Wellington Street, Ottawa, Ontario The media availability will also be h

Parata Systems, a leading provider of pharmacy automation, including vial-filling, adherence packaging, and workflow and patient experience solutions, announces the launch of a new, dual adherence packager for both blister and pouch

Study Shows PixCell’s HemoScreen™ May Be Used to Monitor Pathological Blood Samples, Improving Treatment Process for Hematological Patients

Almirall, S.A. (ALM) announced today that it has signed an agreement with the French Authorities to make the biologic treatment ILUMETRI® (tildrakizumab), a high-affinity IL-23p19 monoclonal antibody, available in France for the treatment of adult patients with severe plaque psoriasis who are candidates for biological systemic therapy.

InMode Ltd. (Nasdaq: INMD ), a leading global provider of innovative medical technologies, announced today that it will release its financial results for the third quarter 2020 before the Nasdaq market opens on T

The 2.5 mm stent and 120 cm OTW balloon catheter will make it possible for more patients with CLI to be treated, reducing the rate of amputation. [13-October-2020] WILMINGTON, Mass. , Oct. 13, 2020 /PRNewswire/ -- Micro Medical Solutions (MMS) today announced CE Mark approval for the 2.5 mm MicroStent vascular stent, the smallest diameter MicroStent to date. Also gra

Disease education program aims to help patients, caregivers and families affected by Fabry disease to make informed healthcare decisions Program includes new resources for healthcare professionals to support strategies in diagnosis and disease management

Without directly invading the brain or nerves, the virus responsible for COVID-19 causes potentially damaging neurological injuries in about one in seven infected, a new study shows.

Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst & Investor Meeting on Monday, October 26 th , 2020 in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting. Presentations will begin at 1:00 pm ET ( 10:00 am PT ) and will conclude at 3:00 pm ET (12:0